Steve Valiquette
Stock Analyst at Barclays
(1.54)
# 3,402
Out of 5,182 analysts
147
Total ratings
47.42%
Success rate
-1.95%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $8 → $9.5 | $13.77 | -31.01% | 6 | Nov 10, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $5.25 | +128.57% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $873.43 | -29.47% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $2.16 | +316.67% | 7 | Mar 1, 2024 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $17.58 | +36.52% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $78.84 | +9.08% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $37.55 | +126.36% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $507.19 | -40.85% | 4 | Jun 28, 2023 | |
| LTC LTC Properties | Maintains: Underweight | $35 → $34 | $39.55 | -14.03% | 3 | May 3, 2023 | |
| THC Tenet Healthcare | Maintains: Overweight | $70 → $105 | $201.87 | -47.99% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $84.95 | -35.26% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $20.35 | -36.12% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $187.88 | -24.42% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $32.60 | -84.66% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $108.33 | -47.38% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $206.34 | -60.26% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $16.69 | +7.85% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $45.72 | -32.20% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $145.05 | +158.53% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $39.42 | -51.80% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $197.32 | +188.87% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $215.80 | -70.34% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $278.45 | +11.33% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $306.91 | +84.09% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $1.05 | +7,042.86% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $8.49 | +123.79% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.15 | +217.46% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $6.61 | +202.57% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $79.53 | +226.92% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8 → $9.5
Current: $13.77
Upside: -31.01%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $5.25
Upside: +128.57%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $873.43
Upside: -29.47%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $2.16
Upside: +316.67%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $17.58
Upside: +36.52%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $78.84
Upside: +9.08%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $37.55
Upside: +126.36%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $507.19
Upside: -40.85%
LTC Properties
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $39.55
Upside: -14.03%
Tenet Healthcare
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $201.87
Upside: -47.99%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $84.95
Upside: -35.26%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $20.35
Upside: -36.12%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $187.88
Upside: -24.42%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $32.60
Upside: -84.66%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $108.33
Upside: -47.38%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $206.34
Upside: -60.26%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $16.69
Upside: +7.85%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $45.72
Upside: -32.20%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $145.05
Upside: +158.53%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $39.42
Upside: -51.80%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $197.32
Upside: +188.87%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $215.80
Upside: -70.34%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $278.45
Upside: +11.33%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $306.91
Upside: +84.09%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $1.05
Upside: +7,042.86%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $8.49
Upside: +123.79%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.15
Upside: +217.46%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $6.61
Upside: +202.57%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $79.53
Upside: +226.92%